The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome

Published:2023-01 Issue: Volume:166 Page:116598
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Sugarman Jeffrey,Maruri Ann,Hamilton Dale J.,Tabatabai Laila,Luca Diana,Cimms Tricia,Krolczyk Stan,Roberts Mary Scott,Carpenter Thomas O.

Funder

Kyowa Hakko Kirin

Ultragenyx Pharmaceutical

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference33 articles.

1. Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment;Ovejero;Osteoporos. Int.,2016

2. Epidermal nevus syndromes: new insights into whorls and swirls;Asch;Pediatr. Dermatol.,2018

3. Burosumab treatment in a child with cutaneous skeletal hypophosphatemia syndrome: a case report;Khadora;Bone Rep,2021

4. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia;Lim;Hum. Mol. Genet.,2014

5. DIAGNOSIS OF ENDOCRINE DISEASE: mosaic disorders of FGF23 excess: fibrous dysplasia/McCune-albright syndrome and cutaneous skeletal hypophosphatemia syndrome;de Castro;Eur. J. Endocrinol.,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A child with cutaneous-skeletal hypophosphatemia syndrome caused by a mosaic HRAS mutation – outcome of treatment with anti-FGF23 antibody;2024-07-03

2. Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia;Endocrinology and Metabolism;2024-04-30

3. Diagnosis, treatment, and management of rickets: a position statement from the Bone and Mineral Metabolism Group of the Italian Society of Pediatric Endocrinology and Diabetology;Frontiers in Endocrinology;2024-04-19

4. Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome;Bone Reports;2024-03

5. Adult epidermal nevus syndrome with hypophosphatemic osteomalacia treated with burosumab: a case study and literature review;Journal of Cutaneous Immunology and Allergy;2024-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3